Xtl Biopharmaceuticals (XTLB) Shares Outstanding (2009 - 2025)

Xtl Biopharmaceuticals (XTLB) has reported Shares Outstanding (Entity) for 11 consecutive years, with $128.6 million the latest figure, recorded in Q2 2019.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $128.6 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $128.6 million (changed 0.0% YoY) and the FY2018 annual result came in at $128.6 million, changed N/A from the prior year.
• Shares Outstanding (Entity) was little changed at $128.6 million in Q2 2019 per XTLB's latest filing, from $128.6 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for XTLB reached as high as $128.6 million in Q1 2018 and fell as low as $11.7 million in Q1 2015.
• A 5-year average of $91.4 million and a median of $106.3 million in 2017 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2015 — Shares Outstanding (Entity) jumped 1669080.18% — and 2019, when it changed 0.0%.
• Year by year, Shares Outstanding (Entity) stood at $65.9 million in 2015, then advanced by 3.91% to $68.5 million in 2016, then jumped by 66.15% to $113.8 million in 2017, then advanced by 12.94% to $128.6 million in 2018, then changed by 0.0% to $128.6 million in 2019.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $128.6 million, $128.6 million, and $128.6 million for Q2 2019, Q1 2019, and Q4 2018 respectively.